Capital and reserves (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
|---|
| Disclosure of terms and conditions of share-based payment arrangement [line items] |
|
| Schedule of share capital |
| |
|
2025
|
|
|
2024
|
|
| |
|
|
|
|
|
|
|
Number of ordinary shares (issued and paid up):
|
|
|
|
|
|
|
|
Balance at the beginning of the year
|
|
|
120,423,333
|
|
|
|
120,286,627
|
|
|
Exercise of share options (cashless)
|
|
|
42,575
|
|
|
|
136,706
|
|
|
Balance at the end of the year
|
|
|
120,465,908
|
|
|
|
120,423,333
|
|
|
| Schedule of share-based payment arrangements |
|
Grant Date
|
|
Number of instruments
|
|
Instrument terms
|
|
Vesting terms
|
|
Contractual life
|
|
August 2023
March 2024
November 2024
|
|
80,868
43,160
34,827
|
|
Each option is exercisable into one ordinary share on a cash-less basis.
|
|
These options shall vest upon the first, second, third and fourth anniversary, in four equal instalments of 25% each.
|
|
5 years
|
|
| Schedule of measurement inputs for fair value of options |
|
Granted in
|
|
November 2024
|
|
March 2024
|
|
August 2023
|
|
|
|
Grant date fair value
|
|
USD 14.41
|
|
USD 4.94
|
|
USD 7.06
|
|
|
|
Share price on grant date
|
|
USD 26.10
|
|
USD 10.99
|
|
USD 14.26
|
|
|
|
Exercise price
|
|
USD 22.71
|
|
USD 12.48
|
|
USD 13.84
|
|
|
|
Expected volatility
|
|
54.0%
|
|
50.5%
|
|
50.1%
|
|
|
|
Expected life
|
|
5 years
|
|
5 years
|
|
5 years
|
|
|
|
Expected dividends (*)
|
|
0%
|
|
0%
|
|
0%
|
|
|
|
Risk-free interest rate
|
|
4.5%
|
|
4.1%
|
|
4.3%
|
|
|
(*) Options’ exercise price is adjusted in respect of dividend distributions.
|
| Schedule of reconciliation of outstanding share options |
| |
|
2025
|
|
|
2024
|
|
|
2023
|
|
| |
|
Issuable shares
|
|
|
Weighted average exercise price
|
|
|
Issuable shares
|
|
|
Weighted average exercise price
|
|
|
Issuable shares
|
|
|
Weighted average exercise price
|
|
|
Outstanding at the beginning of the
period
|
|
|
2,100,107
|
|
|
|
28.52
|
|
|
|
2,238,787
|
|
|
|
32.36
|
|
|
|
2,461,430
|
|
|
|
37.05
|
|
|
Granted during the year
|
|
|
|
|
|
|
|
|
|
|
77,987
|
|
|
|
12.76
|
|
|
|
80,868
|
|
|
|
13.84
|
|
|
Exercised during the year
|
|
|
(45,206
|
)
|
|
|
1.03
|
|
|
|
(136,706
|
)
|
|
|
0.00 |
|
|
|
(136,706
|
)
|
|
|
0.00 |
|
|
Forfeited during the year
|
|
|
(74,396
|
)
|
|
|
|
|
|
|
(79,961
|
)
|
|
|
|
|
|
|
(166,805
|
)
|
|
|
|
|
|
Outstanding at the end of the period
|
|
|
1,980,505
|
|
|
|
25.46
|
|
|
|
2,100,107
|
|
|
|
28.52
|
|
|
|
2,238,787
|
|
|
|
32.36
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at the end of the period
|
|
|
1,425,604
|
|
|
|
24.97
|
|
|
|
965,791
|
|
|
|
29.39
|
|
|
|
513,115
|
|
|
|
11.74
|
|
|
| Schedule of earnings (loss) per share |
| |
|
2025
|
|
|
2024
|
|
|
2023
|
|
| |
|
US $ in millions
|
|
Profit (loss) attributable to ordinary shareholders used to calculate basic and diluted
earnings per share (US $ in millions)
|
|
|
479.2
|
|
|
|
2,147.7
|
|
|
|
(2,695.6
|
)
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
Number of outstanding shares at the beginning of the period used to calculate basic
earnings per share
|
|
|
120,423,333
|
|
|
|
120,286,627
|
|
|
|
120,149,921
|
|
|
Effect of share options
|
|
|
30,338
|
|
|
|
70,688
|
|
|
|
63,110
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of ordinary shares used to calculate basic earnings per share
|
|
|
120,453,671
|
|
|
|
120,357,315
|
|
|
|
120,213,031
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of share options
|
|
|
62,183
|
|
|
|
135,110
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of ordinary shares used to calculate diluted earnings per
share
|
|
|
120,515,854
|
|
|
|
120,492,425
|
|
|
|
120,213,031
|
|
|